Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
Authors
Keywords
Intranasal, Parkinson’s disease, GDNF, Nanoparticles, Neuroprotection
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-20
DOI
10.1007/s12035-018-1109-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA Nanoparticles: Detection of Long-Term Transgene Activity in Brain using Bioluminescence Imaging
- (2018) David M. Yurek et al. Molecular Imaging
- Intracerebral injections of DNA nanoparticles encoding for a therapeutic gene provide partial neuroprotection in an animal model of neurodegeneration
- (2017) David Yurek et al. Nanomedicine-Nanotechnology Biology and Medicine
- Paravascular channels, cisterns, and the subarachnoid space in the rat brain: A single compartment with preferential pathways
- (2016) Beatrice Bedussi et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier
- (2015) Amirah E-E Aly et al. Expert Opinion on Drug Delivery
- Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration
- (2015) Jeffrey J Lochhead et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Trophic factors for Parkinson's disease: To live or let die
- (2015) C. Warren Olanow et al. MOVEMENT DISORDERS
- Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats
- (2015) T.S. Bender et al. NEUROSCIENCE
- Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain
- (2014) B T Harmon et al. GENE THERAPY
- Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
- (2014) M.M. Migliore et al. NEUROSCIENCE
- Comparison of Fetal Mesencephalic Grafts, AAV-delivered GDNF, and Both Combined in an MPTP-induced Nonhuman Primate Parkinson’s Model
- (2013) D Eugene Redmond et al. MOLECULAR THERAPY
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic Brain
- (2012) Il-Doo Kim et al. MOLECULAR THERAPY
- Intranasal delivery of biologics to the central nervous system
- (2011) Jeffrey J. Lochhead et al. ADVANCED DRUG DELIVERY REVIEWS
- Intranasal delivery of therapeutic proteins for neurological diseases
- (2011) Francesca Malerba et al. Expert Opinion on Drug Delivery
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor
- (2011) A.M. Fletcher et al. NEUROSCIENCE
- A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain
- (2011) Y. Jiang et al. NEUROSCIENCE
- Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa
- (2009) Xue Cai et al. FASEB JOURNAL
- Brain delivery of proteins by the intranasal route of administration: A comparison of cationic liposomes versus aqueous solution formulations
- (2009) Mattia M. Migliore et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
- (2009) Shyeilla V. Dhuria et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
- (2009) David M Yurek et al. MOLECULAR THERAPY
- Nigrostriatal rAAV-mediated GDNF Overexpression Induces Robust Weight Loss in a Rat Model of Age-related Obesity
- (2009) Fredric P Manfredsson et al. MOLECULAR THERAPY
- GDNF isoform affects intracellular trafficking and secretion of GDNF in neuronal cells
- (2008) Yue Wang et al. BRAIN RESEARCH
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Delivery of interferon-β to the monkey nervous system following intranasal administration
- (2008) R.G. Thorne et al. NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started